TXMD logo

TherapeuticsMD (TXMD) CAPEX

Annual CAPEX

N/A

31 December 2023

TXMD CAPEX Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly CAPEX

N/A

30 September 2024

TXMD Quarterly CAPEX Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM CAPEX

N/A

30 September 2024

TXMD TTM CAPEX Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TXMD CAPEX Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year---
3 y3 years---
5 y5 years---

TXMD CAPEX High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years
5 y5 years
alltimeall time

TherapeuticsMD CAPEX History

DateAnnualQuarterlyTTM
Dec 2022
$355.00 K(-84.0%)
$74.00 K(-1157.1%)
$355.00 K(-80.2%)
Sept 2022
-
-$7000.00(-109.2%)
$1.79 M(-9.5%)
June 2022
-
$76.00 K(-64.2%)
$1.98 M(-0.7%)
Mar 2022
-
$212.00 K(-86.0%)
$2.00 M(-10.2%)
Dec 2021
$2.22 M(+39.1%)
$1.51 M(+731.9%)
$2.22 M(+84.8%)
Sept 2021
-
$182.00 K(+104.5%)
$1.20 M(-6.2%)
June 2021
-
$89.00 K(-79.7%)
$1.28 M(-19.5%)
Mar 2021
-
$438.00 K(-11.3%)
$1.59 M(-0.3%)
Dec 2020
$1.60 M(-93.3%)
$494.00 K(+88.5%)
$1.60 M(-92.7%)
Sept 2020
-
$262.00 K(-34.3%)
$21.84 M(-4.5%)
June 2020
-
$399.00 K(-9.9%)
$22.88 M(-3.3%)
Mar 2020
-
$443.00 K(-97.9%)
$23.67 M(-0.9%)
Dec 2019
$23.89 M(+12.1%)
$20.73 M(+1492.2%)
$23.89 M(+551.9%)
Sept 2019
-
$1.30 M(+9.4%)
$3.67 M(-83.9%)
June 2019
-
$1.19 M(+78.7%)
$22.70 M(+4.0%)
Mar 2019
-
$665.90 K(+31.3%)
$21.82 M(+2.3%)
Dec 2018
$21.32 M(+2478.0%)
$507.20 K(-97.5%)
$21.32 M(+0.7%)
Sept 2018
-
$20.33 M(+6430.1%)
$21.17 M(+2241.2%)
June 2018
-
$311.40 K(+84.3%)
$904.10 K(+5.0%)
Mar 2018
-
$169.00 K(-51.9%)
$860.80 K(+4.1%)
Dec 2017
$827.10 K(-33.4%)
$351.50 K(+386.8%)
$827.10 K(-4.7%)
Sept 2017
-
$72.20 K(-73.1%)
$867.60 K(-12.1%)
June 2017
-
$268.10 K(+98.2%)
$986.50 K(-18.6%)
Mar 2017
-
$135.30 K(-65.5%)
$1.21 M(-2.4%)
Dec 2016
$1.24 M(+112.4%)
$392.00 K(+105.1%)
$1.24 M(-4.5%)
Sept 2016
-
$191.10 K(-61.3%)
$1.30 M(+13.2%)
June 2016
-
$493.20 K(+198.9%)
$1.15 M(+61.2%)
Mar 2016
-
$165.00 K(-63.4%)
$712.50 K(+21.9%)
Dec 2015
$584.40 K(-5.3%)
$450.80 K(+1050.0%)
$584.40 K(+11.0%)
Sept 2015
-
$39.20 K(-31.8%)
$526.70 K(+12.6%)
June 2015
-
$57.50 K(+55.8%)
$467.80 K(-12.3%)
Mar 2015
-
$36.90 K(-90.6%)
$533.40 K(-13.6%)
Dec 2014
$617.40 K(+28.7%)
$393.10 K(-2095.4%)
$617.50 K(+46.1%)
Sept 2014
-
-$19.70 K(-116.0%)
$422.80 K(-28.2%)
June 2014
-
$123.10 K(+1.7%)
$588.80 K(+18.5%)
Mar 2014
-
$121.00 K(-39.0%)
$496.90 K(+3.6%)
Dec 2013
$479.80 K(+76.1%)
$198.40 K(+35.6%)
$479.80 K(+20.9%)
Sept 2013
-
$146.30 K(+368.9%)
$396.80 K(+35.9%)
June 2013
-
$31.20 K(-70.0%)
$292.00 K(-12.0%)
Mar 2013
-
$103.90 K(-10.0%)
$331.90 K(+21.8%)
Dec 2012
$272.50 K
$115.40 K(+178.1%)
$272.50 K(+64.2%)
DateAnnualQuarterlyTTM
Sept 2012
-
$41.50 K(-41.6%)
$166.00 K(+30.4%)
June 2012
-
$71.10 K(+59.8%)
$127.30 K(+78.8%)
Mar 2012
-
$44.50 K(+400.0%)
$71.20 K(+89.4%)
Dec 2011
$37.60 K(+37.7%)
$8900.00(+217.9%)
$37.60 K(+31.0%)
Sept 2011
-
$2800.00(-81.3%)
$28.70 K(+10.8%)
June 2011
-
$15.00 K(+37.6%)
$25.90 K(+137.6%)
Mar 2011
-
$10.90 K(-92.3%)
$10.90 K(-98.7%)
Dec 2010
$27.30 K(-96.8%)
-
-
Dec 2009
$841.30 K(+1358.1%)
$141.30 K(-79.8%)
$841.30 K(+20.2%)
Sept 2009
-
$700.00 K(-1190.3%)
$700.00 K(>+9900.0%)
Dec 2007
-
-$64.20 K(-255.1%)
$0.00(-100.0%)
Sept 2007
-
$41.40 K(>+9900.0%)
$121.90 K(+306.3%)
June 2007
-
$0.00(-100.0%)
$30.00 K(-57.1%)
Mar 2007
-
$22.80 K(-60.5%)
$70.00 K(+21.3%)
Dec 2006
$57.70 K(-37.4%)
$57.70 K(-214.3%)
$57.70 K(-37.4%)
Sept 2006
-
-$50.50 K(-226.3%)
$92.20 K(-35.4%)
June 2006
-
$40.00 K(+281.0%)
$142.70 K(+146.5%)
Mar 2006
-
$10.50 K(-88.6%)
$57.90 K(-37.2%)
Dec 2005
$92.20 K(-70.4%)
$92.20 K(-305.8%)
$92.20 K(-56.7%)
June 2005
-
-$44.80 K(-200.0%)
$213.00 K(-26.0%)
Mar 2005
-
$44.80 K(-85.6%)
$288.00 K(-7.4%)
Dec 2004
$311.10 K(+25.6%)
$311.10 K(-417.1%)
$311.00 K(+278.8%)
Sept 2004
-
-$98.10 K(-424.8%)
$82.10 K(-66.8%)
June 2004
-
$30.20 K(-55.5%)
$247.50 K(-19.0%)
Mar 2004
-
$67.80 K(-17.5%)
$305.50 K(+23.3%)
Dec 2003
$247.70 K(+295.1%)
$82.20 K(+22.1%)
$247.70 K(+38.7%)
Sept 2003
-
$67.30 K(-23.7%)
$178.60 K(+60.5%)
June 2003
-
$88.20 K(+782.0%)
$111.30 K(+53.1%)
Mar 2003
-
$10.00 K(-23.7%)
$72.70 K(+15.9%)
Dec 2002
$62.70 K(+188.9%)
$13.10 K(>+9900.0%)
$62.70 K(+26.4%)
Sept 2002
-
$0.00(-100.0%)
$49.60 K(-25.0%)
June 2002
-
$49.60 K(>+9900.0%)
$66.10 K(+204.6%)
Dec 2001
$21.70 K(-89.7%)
$0.00(-100.0%)
$21.70 K(0.0%)
Sept 2001
-
$16.50 K(+217.3%)
$21.70 K(+317.3%)
June 2001
-
$5200.00
$5200.00
Dec 1998
$211.40 K(+121.6%)
-
-
Dec 1997
$95.40 K(+500.0%)
-
-
Dec 1996
$15.90 K(+50.0%)
-
-
Dec 1995
$10.60 K(-84.9%)
-
-
Dec 1994
$70.40 K(-21.8%)
-
-
Dec 1993
$90.00 K
-
-

FAQ

  • What is the all time high annual CAPEX for TherapeuticsMD?
  • What is the all time high quarterly CAPEX for TherapeuticsMD?
  • What is the all time high TTM CAPEX for TherapeuticsMD?

What is the all time high annual CAPEX for TherapeuticsMD?

TherapeuticsMD all-time high annual capital expenditures is $23.89 M

What is the all time high quarterly CAPEX for TherapeuticsMD?

TherapeuticsMD all-time high quarterly capital expenditures is $20.73 M

What is the all time high TTM CAPEX for TherapeuticsMD?

TherapeuticsMD all-time high TTM capital expenditures is $23.89 M